Stay updated on Canakinumab & Pembrolizumab Combo in Early NSCLC Clinical Trial

Sign up to get notified when there's something new on the Canakinumab & Pembrolizumab Combo in Early NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Canakinumab & Pembrolizumab Combo in Early NSCLC Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Recruitment status updated to 'No longer looking for participants,' indicating termination due to low enrollment. The study record version updated to v3.6.0, replacing the previous v3.5.5.
    Difference
    0.4%
    Check dated 2026-06-12T23:43:51.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    A new revision tag v3.5.5 is added to the page history, replacing v3.5.4, indicating an update to the record.
    Difference
    0.1%
    Check dated 2026-06-05T17:22:07.000Z thumbnail image
  4. Check
    38 days ago
    Change Detected
    Summary
    Added a new revision entry v3.5.4 to the record history. The previous revision v3.5.3 was removed from the history.
    Difference
    0.1%
    Check dated 2026-05-15T05:49:45.000Z thumbnail image
  5. Check
    59 days ago
    Change Detected
    Summary
    A page revision/version identifier was updated from v3.5.2 to v3.5.3 on the study’s record history page.
    Difference
    0.1%
    Check dated 2026-04-24T04:31:34.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-16T21:32:23.000Z thumbnail image
  7. Check
    95 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added to the Record History and Revision: v3.4.3 was removed.
    Difference
    0.1%
    Check dated 2026-03-18T21:50:24.000Z thumbnail image

Stay in the know with updates to Canakinumab & Pembrolizumab Combo in Early NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Canakinumab & Pembrolizumab Combo in Early NSCLC Clinical Trial page.